Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 9

1.

GITR activation induces an opposite effect on alloreactive CD4(+) and CD8(+) T cells in graft-versus-host disease.

Muriglan SJ, Ramirez-Montagut T, Alpdogan O, Van Huystee TW, Eng JM, Hubbard VM, Kochman AA, Tjoe KH, Riccardi C, Pandolfi PP, Sakaguchi S, Houghton AN, Van Den Brink MR.

J Exp Med. 2004 Jul 19;200(2):149-57. Epub 2004 Jul 12.

2.
3.

GITR: a modulator of immune response and inflammation.

Nocentini G, Riccardi C.

Adv Exp Med Biol. 2009;647:156-73. doi: 10.1007/978-0-387-89520-8_11. Review.

PMID:
19760073
4.

[CD4+, CD25+ regulatory T-lymphocytes: current concepts and therapeutic potential].

Salomon B.

J Soc Biol. 2002;196(4):263-6. Review. French.

PMID:
12645292
5.
6.

Glucocorticoid-induced TNFR-related (GITR) protein and its ligand in antitumor immunity: functional role and therapeutic modulation.

Placke T, Kopp HG, Salih HR.

Clin Dev Immunol. 2010;2010:239083. doi: 10.1155/2010/239083. Epub 2010 Sep 26. Review.

7.

Suppression of graft-versus-host disease by naturally occurring regulatory T cells.

Zeng D, Lan F, Hoffmann P, Strober S.

Transplantation. 2004 Jan 15;77(1 Suppl):S9-S11. Review.

PMID:
14726761
8.

CD8+ T cells: GITR matters.

Ronchetti S, Nocentini G, Petrillo MG, Riccardi C.

ScientificWorldJournal. 2012;2012:308265. doi: 10.1100/2012/308265. Epub 2012 Apr 30. Review.

9.

Apoptosis in AIDS. Genetic control and relevance for AIDS pathogenesis.

Gougeon ML.

Biochem Soc Trans. 1996 Nov;24(4):1055-8. Review. No abstract available.

PMID:
8968511
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk